Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes

Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes

Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer’s disease (AD) in its advanced stages. It also potentially represents a biomarker for progression of this disease. Based on the crystal structure of previously described highly potent, revers...

Descripció completa

Dades bibliogràfiques
Autors principals: Stane Pajk, Damijan Knez, Urban Košak, Maja Zorović, Xavier Brazzolotto, Nicolas Coquelle, Florian Nachon, Jacques-Philippe Colletier, Marko Živin, Jure Stojan, Stanislav Gobec
Format: Article
Idioma:English
Publicat: Taylor & Francis Group 2020-01-01
Col·lecció:Journal of Enzyme Inhibition and Medicinal Chemistry
Matèries:
butyrylcholinesterase
inhibitor
probe
fluorescence
Accés en línia:http://dx.doi.org/10.1080/14756366.2019.1710502

Internet

http://dx.doi.org/10.1080/14756366.2019.1710502

Ítems similars